Long-term open-label perampanel: Generalized tonic-clonic seizures in idiopathic generalized epilepsy.

Jacqueline A FrenchRobert T WechslerEugen Trinka Christian BrandtTerence J O'BrienAnna PattenAlejandro SalahManoj Malhotra

Published in: Epilepsia open (2022)

Perampanel was generally well-tolerated, and the TEAEs reported here are consistent with the known safety profile of perampanel. Perampanel offers a long-term treatment option for patients (aged ≥12 years) with GTC seizures.

Keyphrases

open label
end stage renal disease
ejection fraction
newly diagnosed
clinical trial
prognostic factors
peritoneal dialysis
patient reported outcomes
phase ii
smoking cessation